About Transolam
Transolam is a venture capital firm founded in 2008. It is primarily based out of Beverly Hills, United States. It primarily invests in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Overall, Transolam portfolio has seen 2 unicorns, 1 IPO and 8 acquisitions including key companies like Ayar Labs, Visby Medical and Lang. Transolam has team of 2 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Portfolio IPOs
Portfolio Unicorns
Transolam's List of Top Investments
Transolam has a portfolio of 52 companies, including 2 unicorns. Their most notable investments include Ayar Labs and XTEND.Their portfolio spans across United States, Israel, Cyprus and 1 more locations. They have invested in Enterprise Applications, High Tech, Life Sciences and 21 other sectors. Here is the list of top investments by Transolam:
1. Ayar Labs
Developer of optical interconnect solutions for artificial intelligence infrastructure applications. The company provides optical I/O chiplets and light sources for enhanced bandwidth and power efficiency. These solutions aim to improve the performance and scalability of AI and high-performance computing systems. The company's products are intended for use in data centers and other advanced technology applications.
Key facts about Ayar Labs
- Founded Year: 2015
- Location: San Jose (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $1.02B
- Employee Count: 258 as on Aug 31, 2026
- Investors: Intel, Rising Tide Fund and 58 Others
- Latest Funding Round: Series E, Sep 10, 2026, $*****
- Highlight: Editors' Pick
2. XTEND
Developer of AI-assisted tactical unmanned aerial systems for military use. The company provides remotely operated multi-robot systems designed to enhance combat effectiveness and operator safety. Its platforms support various modular payloads and integration with third-party software. The systems offer intuitive control for complex missions and adaptability in dynamic combat environments.
Key facts about XTEND
3. InnerPlant
Developer of engineered plants that communicate stress for improved crop management. The plants emit optical signals detectable in the field, indicating stress from pathogens, nutrient deficiencies, or drought. A platform translates these signals into actionable recommendations for farmers. This enables more productive, profitable, and sustainable farming practices through early warnings and optimized resource allocation.
Key facts about InnerPlant
- Founded Year: 2018
- Location: Davis (United States)
- Stage: Series B
- Total Funding till date: $58.9M
- Employee Count: 48 as on Aug 31, 2026
- Investors: Bee Partners, MS&AD Ventures and 17 Others
- Latest Funding Round: Series B, Jul 25, 2024, $*****
- Highlight: Editors' Pick
Provider of at-home tests for sexually transmitted infections with telehealth. The company provides testing for common curable sexually transmitted infections. If the test is positive, connection to a third-party licensed provider for treatment is included. The test results are available within thirty minutes using PCR technology.
Key facts about Visby Medical
- Founded Year: 2010
- Location: San Jose (United States)
- Valuation: $*****
- Stage: Series F
- Total Funding till date: $386M
- Employee Count: 180 as on May 31, 2026
- Investors: E Squared Capital, Artiman and 28 Others
- Latest Funding Round: Series F, Jun 18, 2025, $*****
- Highlight: Editors' Pick
5. Pontera
Tax management solutions for businesses. It offers solutions for account trading and management, financial regulatory management, compliance management, data protection, and more. It also offers wealth management solutions.
Key facts about Pontera
- Founded Year: 2012
- Location: New York City (United States)
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $160M
- Employee Count: 256 as on Aug 31, 2026
- Investors: ThirdStream Partners, Collab Fund and 11 Others
- Latest Funding Round: Series C, Dec 07, 2023, $*****
- Highlight: Editors' Pick
Unicorns in Transolam's Portfolio
Transolam has 2 unicorns in its portfolio - Ayar Labs and Visby Medical. The most recent unicorn in their portfolio is Ayar Labs. It became a unicorn in 2024, 1 years before Transolam first invested in it.Here is a list of unicorns in Transolam's portfolio:
Filter this listTracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
67 | Developer of optical interconnect solutions for artificial intelligence infrastructure applications | 2015 | San Jose | Series E | zewss{w | ||
63 | Provider of at-home tests for sexually transmitted infections with telehealth | 2010 | San Jose | Series F | vifttpj |
IPOs and Publicly Listed companies in Transolam's Portfolio
1 of Transolam's portfolio company became public - Save Foods. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Nov 2010.Here are Transolam's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 18, 2010 | - | - | 8394 |
Acquired companies in Transolam's Portfolio
8 companies from Transolam's portfolio have been acquired. The most recent acquisition was Lang in Apr 2026 by Capacity for $*****.Here are Transolam's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 21, 2026 | - | - | 4423 | |
Jan 23, 2025 | - | - | 1255 | |
Mar 21, 2024 | - | - | 5320 | |
Apr 26, 2023 | - | - | 7898 | |
Apr 26, 2023 | - | - | 6741 |
